Project Grant HT94252510248
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$860K
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
The Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $201,000 Project Grant to Yale University on March 1, 2025. The grant supports advanced biomedical research focused on investigating the role of the RBM10 gene in the histologic transformation to lung squamous cell carcinoma. This research aims to transform healthcare for military service members and the broader public by advancing the scientific...
This $159,900 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports preclinical research on brain metastases in lung cancer. The award will fund studies at the University of Illinois to develop and evaluate novel drug efficacy and resistance models for advancing the treatment of brain metastases, a significant challenge in lung cancer management. Spanning one year from August 2024 to August...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
The Yale University was awarded a $1,244,745 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 to June 2025 to overcome resistance to EGFR inhibitors in advanced head and neck cancers. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award will further...
The Yale University was awarded a $753,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2022 through March 2025 to target replication stress in triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This federal Project Grant award of $837,497.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Yale University, the award recipient, will conduct research on "Feeding Stress Primes the Pancreas for Cancer" over the performance period from November 1, 2024 to October 31,...
This federal Project Grant award of $808,141, issued by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research targeting inflammatory pathways in breast cancer brain metastases. The award provides funding to Weill Medical College of Cornell University, a leading academic medical institution, to conduct research on using anti-VEGF ultrasmall particle therapy for the treatment of edema and radiation necrosis. The...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
This $188,403 federal Project Grant award was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Los Angeles (UCLA) for the development of new cell-mediated immunotherapeutic strategies for small-cell lung cancer. The award has a performance period from January 1, 2025 to December 31, 2025. The funding supports advanced biomedical research initiatives focused on transforming...
The Department of the Army Medical Command awarded Yale University a $1,004,997 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund Yale University's pilot development of new forms of chimeric antigen receptor therapies for kidney cancer from August 15, 2021 to August 14, 2024. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...